By Edward Winnick
NEW YORK (GenomeWeb News) – A Sequenom official yesterday provided an update on the firm's timeline for commercialization of its highly anticipated trisomy 21 non-invasive, pre-natal test.
Registering provides access to this and other free content.
Already have an account?Login Now.
Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.
In Nature this week: a Danish reference genome, and more.